CAMBRIAN BIOPHARMA INC
Profile
Company Names
CAMBRIAN BIOPHARMA INC
Addresses
228 PARK AVENUE S., #66643, NEW YORK, NY 10003
19 MORRIS AVENUE, BROOKLYN NAVY YARD, BUILDING 128, BROOKLYN, NY 11205
Phone Numbers
(516) 962-3186
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2019
State Incorporated:
DELAWARE
Total Amount Raised:
$148,416,656.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-06-02
$23,022,065.00
$37,602,297.00
$14,580,232.00
3
2021-10-13
$92,209,653.00
$100,775,000.00
$8,565,347.00
Equity
2
2020-10-20
$28,434,938.00
$28,434,938.00
$0.00
Equity, Debt
1
2019-10-29
$4,750,000.00
$4,750,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTIAN
ANGERMAYER
DIRECTOR
PAUL
FARR
DIRECTOR
JAMES
G.
PEYER
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
MARYANNA
SAENKO
DIRECTOR
FUTURE VENTURES, L.P.
| FUTURE VENTURES SIDE FUND, L.P.
| OCKAM INC.
| FUTURE VENTURES FINAL FRONTIER FUND, LLC
| FUTURE VENTURES II, L.P.
| FUTURE VENTURES SIDE FUND II, L.P.
| FUTURE VENTURES FINAL FRONTIER FUND II, LLC
| CAMBRIAN BIOPHARMA INC
| FUTURE VENTURES COMMONWEALTH FUSION FUND, LLC
| GAMETO, INC.
| FUTURE VENTURES FINAL FRONTIER FUND III, LLC
| EARTHSHOT LABS PBC
| FUTURE VENTURES AI, LLC
| FUTURE VENTURES IV, L.P.
| FUTURE VENTURES SIDE FUND IV, L.P.
| REALTA FUSION INC.
| FUTURE VENTURES COMMONWEALTH FUSION FUND II, LLC
| FUTURE VENTURES COMMONWEALTH FUSION FUND II (BLOCKER), LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
